Lykiri, Dr. Bala: Thanks for your responses and clarifications.
In retrospect, my comment was actually based on her signing onto Matt Williams's comment on the JAMA Oncology paper. To me, the original comment and Williams' response to Richard Williams were definitely negative toward DCVAX-L trial results. If so, wouldn't that be Dr. Susan Short's position as well?